The Liver and Immune System: The Eternal Battle in Transplant Settings

Nov 07 2026
Convention Center: Summit 4, The Park @TLM, Hall D
9:45 AM - 10:45 AM

World Class Speakers

Timucin Taner

Presenter
Timucin Taner, MD, PhD, FAASLD

Ju Dong Yang

Presenter
Ju Dong Yang, MD

Kymberly D Watt

Presenter
Kymberly D Watt, MD

Manhal J Izzy

Moderator
Manhal J Izzy, MD

Allison J Kwong

Moderator
Allison J Kwong, MD

Description

This community conversation explores the complex interplay between immunosuppression and the immune system in liver transplantation settings. Expert panelists discuss strategies for safe immunosuppression minimization amid rejection risks, the evolving role of immunotherapy in persons with hepatocellular carcinoma awaiting transplant, and cautious approaches to immunotherapy for de novo malignancies post liver transplant. Attendees gain practical insights into balancing tolerance, rejection management, and oncologic care in contemporary practice.

Presentations

9:45 AM - 10:00 AM
Convention Center - Summit 4, The Park @TLM, Hall D

The Challenge in Balancing Immunosuppression Minimization or Discontinuation With the Risk of Various Types of Rejection

Timucin Taner, MD, PhD, FAASLD | Presenter
10:00 AM - 10:15 AM
Convention Center - Summit 4, The Park @TLM, Hall D

Pretransplant Immunotherapy for Hepatocellular Carcinoma: When to Consider It and When to Stop It?

Ju Dong Yang, MD | Presenter
10:15 AM - 10:30 AM
Convention Center - Summit 4, The Park @TLM, Hall D

Immunotherapy for Post Transplant De Novo Malignancy: Toward a Safer Approach

Kymberly D Watt, MD | Presenter

Objectives

  • Summarize the risks and benefits of immunosuppression minimization and the nuances of associated rejection types.
  • Recognize the implications of using immunotherapy pretransplant for hepatocellular carcinoma.
  • Discuss the feasibility and drawbacks of using immunotherapy for de novo malignancy post liver transplant.

Copyright © 2026 American Association for the Study of Liver Diseases

AASLD 2026